Exploring the Impact of Probiotics Supplementation on Gut Microbiota Composition and Host Metabolism in Individuals with Obesity

Project Abstract

Obesity is a significant public health concern worldwide, with detrimental effects on overall health and well-being. Emerging research suggests that the gut microbiota plays a crucial role in regulating metabolism and energy balance, making it a potential target for interventions to combat obesity. Probiotics, live microorganisms that confer health benefits when consumed in adequate amounts, have gained attention for their potential to modulate gut microbiota composition and improve metabolic outcomes. This research project aims to explore the impact of probiotics supplementation on gut microbiota composition and host metabolism in individuals with obesity. The study will involve a randomized controlled trial where individuals with obesity will be assigned to either a probiotics supplementation group or a placebo group. The probiotics supplement will contain a specific strain or combination of strains known for their potential beneficial effects on gut health. Participants will undergo baseline assessments of gut microbiota composition, metabolic parameters, and anthropometric measurements before starting the intervention. Throughout the study period, participants will be monitored for changes in gut microbiota diversity, metabolic markers, and body weight. The literature review will provide a comprehensive overview of previous studies investigating the effects of probiotics on gut microbiota and metabolic health in individuals with obesity. Key findings and gaps in the existing literature will be identified to provide context for the current study. The research methodology will detail the study design, participant recruitment criteria, intervention protocol, data collection methods, and statistical analysis plan. Results from the study will be analyzed and discussed in Chapter Four, focusing on changes in gut microbiota composition, metabolic parameters, and weight loss outcomes in response to probiotics supplementation. The implications of the findings for clinical practice and future research will be explored, highlighting the potential of probiotics as a therapeutic strategy for managing obesity and associated metabolic disorders. In conclusion, this research project will contribute to the growing body of evidence on the role of probiotics in modulating gut microbiota composition and improving metabolic outcomes in individuals with obesity. The findings have the potential to inform the development of personalized probiotic interventions for obesity management and provide insights into the mechanisms underlying the gut-microbiota-host metabolism axis.

Project Overview